77P-28595-68783
1 vaccination
2 coded responses
5 check-ins
2 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 31-35
- ZIP prefix
- 782 / TX
- Registered
- 2021-04-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-01
Dose 1 — Pfizer-BioNTech
-
2021-04-22
Registered in v-safe
-
2021-04-22
Survey response — day 21, dose 1MedDRA: Diplopia, Dizziness, Eye pain, Headache, Office visit, Paraesthesia, Vision blurred, Visual impairment — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Symptoms: - Trouble with eyes focusing (started 4 days after first shot) - double vision - tingling in hands (1 week after shot) - pain in eyes and extreme headaches - dizziness (for just over 2 weeks)- tingling in feet and hands (10 days after shot) · Healthcare visit (other): Have seen an eye doctor and they cant find anything wrong with my vision thats causing these symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Report sent to call center — day 21, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-29
- 2021-05-13
-
2021-07-08
Survey response — 3 months, dose 1MedDRA: Gastrointestinal disorder, Guillain-Barre syndrome — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: GI issues. Was also diagnosed with GBS due to taking the Pfizer vaccine. Lab results indicated that I had the antibodies of said disease.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-08
Report sent to call center — 3 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-07-12
Call successfulParticipant prefers to complete VAERS report online
- 2021-09-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech |
Call center
2 call center cases
2 successful
Free text
Release 7 — day 21, dose 1
Symptoms: - Trouble with eyes focusing (started 4 days after first shot) - double vision - tingling in hands (1 week after shot) - pain in eyes and extreme headaches - dizziness (for just over 2 weeks)- tingling in feet and hands (10 days after shot)
Healthcare visit (other): Have seen an eye doctor and they cant find anything wrong with my vision thats causing these symptoms
Release 9 — 3 months, dose 1
Symptoms: GI issues. Was also diagnosed with GBS due to taking the Pfizer vaccine. Lab results indicated that I had the antibodies of said disease.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Visual impairment | ✓ | ✓ | ✓ |
| SD | Diplopia | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Eye pain | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | ✓ | ✓ | ✓ |
| SD | Guillain-Barre syndrome | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release